Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.
D000368:Aged; D000641:Ammonia / Q000097:blood / Q000378:metabolism; D001927:Brain Diseases / Q000188:drug therapy*; D002400:Cathartics / Q000008:administration & dosage; D002908:Chronic Disease; D003106:Colon / Q000382:microbiology; D003967:Diarrhea / Q000139:chemically induced; D004044:Dietary Proteins; D004187:Disaccharides / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D004569:Electroencephalography; D005243:Feces / Q000382:microbiology; D005260:Female; D006501:Hepatic Encephalopathy / Q000188:drug therapy; D006801:Humans; D007778:Lactobacillus / Q000302:isolation & purification; D008103:Liver Cirrhosis / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000008:administration & dosage; D011168:Portal System; D014510:Urease / Q000378:metabolism
D002400:Cathartics; D004044:Dietary Proteins; D004187:Disaccharides; D000641:Ammonia; D014510:Urease; D009355:Neomycin